0.2101
price down icon90.83%   -2.0799
after-market Handel nachbörslich: .23 0.0199 +9.47%
loading

Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
53.94%
32.56
21.15 25.20 26.51 41.75
Operating Income/Loss
53.94%
-32.56
-21.15 -25.20 -26.51 -41.75
Nonoperating Income/Loss
139.32%
-0.162
0.412 0.061 0.062 0.80
Net Income/Loss
57.78%
-32.72
-20.74 -25.14 -26.45 -40.95
Basic Average Shares
14.29%
72.25
63.22 - 60.57 60.57
Diluted Average Shares
14.29%
72.25
63.22 - 60.57 60.57
Basic Earnings Per Share
36.36%
-0.45
-0.33 - -0.44 -0.68
Diluted Earnings Per Share
36.36%
-0.45
-0.33 - -0.44 -0.68
$18.48
price down icon 0.48%
$9.13
price down icon 6.17%
$10.28
price down icon 0.77%
$7.00
price down icon 4.50%
ANL ANL
$9.55
price down icon 7.10%
$1.42
price down icon 4.05%
Kapitalisierung:     |  Volumen (24h):